A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism.

Author: AnandLovkesh, AroraVinod, BhardwajAnkit, DhamijaRavinder Mohan, JindalAnkur, KumarGuresh, SahneyAmrish, SarinShiv Kumar, SharmaBarjesh Chander, VijayaraghavanRajan

Paper Details 
Original Abstract of the Article :
Parkinsonism like features can be seen in cirrhotics, possibly related to alterations in brain dopamine metabolism, transport and receptor integrity at basal ganglia. Hepatic parkinsonism is often not suspected and only ammonia-reducing therapies are given to such patients. We investigated the effic...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/liv.14024

データ提供:米国国立医学図書館(NLM)

Unlocking the Mystery of Hepatic Parkinsonism: A Double-Blind Randomized Controlled Trial of Bromocriptine

This research explores a fascinating topic—the connection between liver disease and Parkinsonism-like symptoms. The researchers conducted a double-blind randomized controlled trial to investigate the effectiveness of bromocriptine, a medication that targets dopamine pathways, in treating patients with hepatic parkinsonism. This innovative approach aims to identify potential therapeutic options for a challenging neurological condition associated with liver dysfunction.

Dopamine and the Liver: A Complex Relationship

The study's findings suggest that bromocriptine may offer a promising avenue for managing hepatic parkinsonism. The results highlight the potential role of dopamine dysregulation in the development of neurological symptoms in patients with liver disease. This research contributes to our understanding of the complex interplay between the liver and the brain, opening up new avenues for exploring therapeutic strategies for patients with hepatic parkinsonism.

The Importance of Early Diagnosis and Treatment

Hepatic parkinsonism can often go undetected, making early diagnosis and effective treatment crucial. This study underscores the need for a heightened awareness of this condition among healthcare professionals, ensuring prompt diagnosis and appropriate management. The findings encourage a holistic approach to patient care, considering potential neurological complications associated with liver disease.

Dr.Camel's Conclusion

This study is like a camel caravan navigating a treacherous desert, seeking out solutions to a complex medical mystery. The researchers have successfully navigated this challenging terrain, providing valuable insights into the role of dopamine in hepatic parkinsonism. This research offers hope for patients struggling with this condition, and it encourages further investigation into the intricate relationship between the liver and the nervous system.
Date :
  1. Date Completed 2020-05-12
  2. Date Revised 2020-05-12
Further Info :

Pubmed ID

30554466

DOI: Digital Object Identifier

10.1111/liv.14024

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.